Carter S, Tubaro A
Department of Urology, Hammersmith Hospitals Trust and Imperial College School of Medicine, London, UK.
J Endourol. 2000 Oct;14(8):617-25. doi: 10.1089/end.2000.14.617.
The study was designed to explore the relation between prostatic temperature and the clinical outcome of transurethral microwave thermotherapy (TUMT).
Forty-nine patients with symptomatic benign prostatic hyperplasia (BPH) were treated. Baseline evaluation included Madsen score, flowmetry, and pressure-flow study. Two fiberoptic thermosensors were placed in the prostate targeted to the region 10 and 20 mm below the bladder neck and 5 to 15 mm lateral to the prostatic urethra. The TUMT was carried out using either the low-energy (2.0) or high-energy (2.5) Prostasoft program. Follow-up was at 6, 12, and 26 weeks.
A moderate correlation between intraprostatic temperatures and energy output (r = 0.409; P < or = 0.046) and prostate volume (r = 0.303; P < or = 0.0424) was observed. Outlet obstruction was associated with higher temperatures (obstructed 49.6+/-5.8 v unobstructed 46.1+/-4.2 degrees C; P < or = 0.033). A significant relation between temperature and clinical outcome was found. Patients with intraprostatic temperatures <46 degrees, 46-50 degrees, and < or = 50 degrees C had significant differences in Madsen score change (-50%, -68% and -86%) and in maximum flow rate (+26%, +32%, and +48%). Patients with temperatures >50 degrees C had a significant improvement in obstruction status (86% to 18%). A slight worsening in voiding dynamics was observed in patients with temperatures <50 degrees C.
A significant relation exists between intraprostatic temperatures achieved during TUMT and the clinical outcome. Temperatures in excess of 50 degrees C seem to be associated with a greater improvement in lower urinary tract symptoms and bladder outlet obstruction. These data provide a sound rationale for monitoring intraprostatic temperatures and developing invasive thermometry feedback mechanisms for thermal treatments of BPH.
本研究旨在探讨前列腺温度与经尿道微波热疗(TUMT)临床疗效之间的关系。
对49例有症状的良性前列腺增生(BPH)患者进行治疗。基线评估包括马德森评分、尿流率测定和压力-流率研究。将两个光纤温度传感器置于前列腺内,目标位置为膀胱颈下方10毫米和20毫米处以及前列腺尿道外侧5至15毫米处。使用低能量(2.0)或高能量(2.5)的Prostasoft程序进行TUMT。随访时间为6周、12周和26周。
观察到前列腺内温度与能量输出(r = 0.409;P≤0.046)以及前列腺体积(r = 0.303;P≤0.0424)之间存在中度相关性。出口梗阻与较高温度相关(梗阻组49.6±5.8℃,非梗阻组46.1±4.2℃;P≤0.033)。发现温度与临床疗效之间存在显著关系。前列腺内温度<46℃、46 - 50℃和≤50℃的患者在马德森评分变化(-50%、-68%和-86%)以及最大尿流率(+26%、+32%和+48%)方面存在显著差异。温度>50℃的患者梗阻状况有显著改善(86%至18%)。温度<50℃的患者排尿动力学略有恶化。
TUMT期间达到的前列腺内温度与临床疗效之间存在显著关系。超过50℃的温度似乎与下尿路症状和膀胱出口梗阻的更大改善相关。这些数据为监测前列腺内温度以及开发用于BPH热疗的侵入性温度测量反馈机制提供了合理依据。